[Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
date : 3/9/2022
Tags: NCDs, Precision Cancer Medicine, Survey on Healthcare in Japan
![[Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/cancer-survey2021-top_ENG.jpg)
On March 9, 2022, Health and Global Policy Institute (HGPI) released poll data on public opinion about priorities for policies related to cancer genomics and precision medicine.
The new poll, conducted in October over the internet, asked a series of policy-related questions to a group of 1,000 people, selected without exclusion from a monitor panel of a research firm to be representative of the total population of Japan in terms of age, sex, and region.
Research asked participants about their own or family experience with cancer, and about their awareness and understanding of cancer genomics and precision medicine. Most people said that they had no experience with cancer (77.1%), while 10.4% said that someone in their family has had cancer, 3.4% said they themselves have had cancer, 1.5% said that they and someone in their family have had cancer. The remaining 7.6% stated that they preferred not to answer.
In terms of awareness and understanding, 57.2% said that they had never heard of cancer genomics or precision medicine, while 38.6% said they had heard of these treatments but did not know much about them. Just 4.2% said that they felt they were knowledgeable about this topic.
Results related to awareness and understanding were low regardless of cancer history, with an average of only approximately 55% reporting that they have at least heard of cancer genomics or precision medicine.
Respondents were asked about their prior knowledge of the six characteristics of cancer genomics and precision medicine listed below. Regardless of reported understanding about these topics, prior understanding about genomic testing, the timing of testing, and insurance coverage was particularly low. Even among those who reported having high knowledge of cancer genomics and precision medicine (42 respondents), just 9 (21.4%) answered that they knew all of the following points prior to this survey, further suggesting a need for greater awareness raising on this topic.
1. You can’t receive precision medicine at every hospital
2. Genomic tests investigate dozens to hundreds of genomic changes all at once, providing results about the specific characteristics of the patient’s cancer. This allows research into the best treatment for each patient.
3. Only a portion of genomic tests are covered by insurance
4. Genomic tests can only be done at specific time points
5. The probability of a genomic test being able to identify the best treatment for a patient is limited
6. Genomic tests can determine the possibility of a cancer having genomic causes
HGPI will continue to work to raise awareness and advance policy around cancer genomics and precision medicine through its work on non-communicable diseases.
For more information on this project and recent events on it organized by HGPI, please see here.
Top Research & Recommendations Posts
- [Urgent Recommendations] Challenges and Prospects for the Implementation and Execution of the Basic Law and Basic Policy for Child and Maternal Health and Development (February 17, 2023)
- [Public Comment Submission] “Basic Plan for the Promotion of Cancer Control (Draft)” (February 18, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Publication Report] The Children’s Health Project Publishes Family Mental Health Booklet “Nurturing Child and Guardian Mental Health through Our Communication with Children” in Five Languages (February 6, 2023)
- [Activity Report] “AMR & JAPAN’S G7 PRESIDENCY: A Call for Pull Incentives to Drive Innovation” (December 13, 2022)
Featured Posts
-
2022-12-26
[Event Report] The Health and Global Policy Institute Chronic Disease Control Project Holds Advisory Board Meeting for “Engaging and Cooperating with Patients, Citizens, and Communities for Obesity Prevention” (September 22, 2022)
-
2023-03-06
[In the Media] What Healthy Climate Prescription Teaches Us: Health Care’s Approach to the Climate Crisis (Min-Iren Iryo, No. 606; February 24, 2023)
-
2023-03-09
[Event Report] HGPI Special Seminar – Universal Health Coverage in an Era of Antimicrobial Resistance (August 18, 2022)
-
2023-03-15
[Event Report] The Cardiovascular Disease Control Promotion Project, Phase 2. “Current Issues and Prospects for Advancing Cardiovascular Disease Control Promotion Plans in Each Prefecture” (March 15, 2023)